+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nerve Repair and Regeneration Market Report by Surgery, Product, End User, and Region 2023-2028

  • PDF Icon

    Report

  • 148 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5912032
The global nerve repair and regeneration market size reached US$ 7.7 Billion in 2022. Looking forward, the market is expected to reach US$ 14.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.51% during 2022-2028.

Nerve repair and regeneration (NRaR) refers to a neural tissue engineering process used for the treatment of a nerve injury. It facilitates the regrowth of new neurons, glial cells, myelin, axons and synapses. It also aids in restoring the normal functioning of the nerve after nerve damage, which is usually caused by pressure, blunt trauma, stretching or cutting of a nerve. NRaR involves the use of biomaterials and various neuro-stimulation and neuromodulation devices. Biomaterials include nerve conduits, nerve protectors, nerve wraps, and nerve connectors. They are used for direct neuropathy, nerve grafting, stem cell therapy and transcutaneous, transcranial magnetic, spinal cord, deep brain, sacral nerve and vagus nerve stimulation.

Nerve Repair and Regeneration Market Trends

The increasing prevalence of chronic neurological disorders, such as Alzheimer's, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis and multiple system atrophy, is among the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and escalating instances of nerve injuries are providing a thrust to the growth of the market. Hospitals, ambulatory surgical centers (ASCs) and other healthcare institutes across the globe are providing novel NRaR solutions for timely diagnosis and treatment of neurological disorders. Additionally, various technological advancements in stem cell therapy and the development of innovative neuromodulation devices, are acting as other growth-inducing factors. Endogenous stem cells are being widely used in neurogenesis, neural repair and exogenous neural stem cell transplantation for effective repair and replacement of damaged tissues in the central nervous system. Other factors, including rising healthcare expenditures of the masses, along with the significant improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global nerve repair and regeneration market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on surgery, product and end user.

Breakup by Surgery:

  • Direct Nerve Repair/Neurorrhaphy
  • Nerve Grafting
  • Stem Cell Therapy
  • Neurostimulation and Neuromodulation Surgeries

Breakup by Product:

  • Biomaterial
  • Neurostimulation and Neuromodulation Devices
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alafair Biosciences Inc., AxoGen Inc., Baxter International Inc., Boston Scientific Corporation, Collagen Matrix Inc., Integra Lifesciences Corporation, Medtronic plc, Polyganics BV, Soterix Medical Inc., Stryker Corporation and Synapse Biomedical Inc.

Key Questions Answered in This Report

1. What was the size of the global nerve repair and regeneration market in 2022?
2. What is the expected growth rate of the global nerve repair and regeneration market during 2023-2028?
3. What are the key factors driving the global nerve repair and regeneration market?
4. What has been the impact of COVID-19 on the global nerve repair and regeneration market?
5. What is the breakup of the global nerve repair and regeneration market based on the surgery?
6. What is the breakup of the global nerve repair and regeneration market based on the product?
7. What is the breakup of the global nerve repair and regeneration market based on the end user?
8. What are the key regions in the global nerve repair and regeneration market?
9. Who are the key players/companies in the global nerve repair and regeneration market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Nerve Repair and Regeneration Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Surgery
6.1 Direct Nerve Repair/Neurorrhaphy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Nerve Grafting
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Stem Cell Therapy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Neurostimulation and Neuromodulation Surgeries
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Product
7.1 Biomaterial
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Neurostimulation and Neuromodulation Devices
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Spinal Cord Stimulation Devices
7.2.2.2 Deep Brain Stimulation Devices
7.2.2.3 Sacral Nerve Stimulation Devices
7.2.2.4 Vagus Nerve Stimulation Devices
7.2.2.5 Gastric Electric Stimulation Devices
7.2.3 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Alafair Biosciences Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 AxoGen Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Baxter International Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Boston Scientific Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Collagen Matrix Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Integra Lifesciences Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Polyganics BV
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Soterix Medical Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Stryker Corporation
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Synapse Biomedical Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio

Companies Mentioned

  • Abbott Laboratories
  • Alafair Biosciences Inc.
  • AxoGen Inc.
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Collagen Matrix Inc.
  • Integra Lifesciences Corporation
  • Medtronic plc
  • Polyganics BV
  • Soterix Medical Inc.
  • Stryker Corporation
  • Synapse Biomedical Inc.

Methodology

Loading
LOADING...

Table Information